Cello Health Insight US Names New Senior Team

Kathryn Gallant has been promoted to the role of Chief Executive of Cello Health Insight US, and Angie Wheeler to that of President USA. In addition Justine Trinidad, Ed Geiselhart and Kaity Arctander have joined the firm's client facing team.

Gallant joined the business in 2013, after eight years at Hall & Partners, where she latterly served as Managing Partner of US Health. Earlier, she was Director of the Qualitative Institute at NOP World Health. In her new role, she will take on responsibility for growth of Cello Health Insight across the US, with a focus on building the US international revenue stream. Wheeler also joined the business in 2013 from Hall & Partners, having previously been VP, Qualitative Research at Research International. In addition to her current role as CEO of Cello Health Chicago, she will have overall responsibility for building the firm's US domestic market business.

Jane Shirley, CEO Cello Health Insight, comments: 'Kathryn and Angie have worked in partnership, with great success for many years to build Cello Health Insight, US. This development in their roles combined with the new additions opens up further leadership opportunities for the team and truly supports our ability to drive growth and expand the business'.

Trinidad joins as US Director of 'IQ', Cello Health's quant practice, with twenty years' industry experience gained at Pacira Pharmaceuticals, Nielsen and Ipsos-Vantis. Geiselhart joins from Insight Product Development, where he was the Director of User Experience and Innovation; while Arctander previously spent four years at medical MR provider Verilogue.

Web site: www.cellohealth.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.